AxoGen (AXGN) Tops Q3 EPS by 7c

AxoGen (NASDAQ: AXGN) reported Q3 EPS of $0.01, $0.07 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $41.3 million versus the consensus estimate of $40.45 million.

For earnings history and earnings-related data on AxoGen (AXGN) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Alimentation Couche-Tard Inc (ATD/B:CN) (ANCUF) PT Raised to Cdn$104 at UBS
• H.C. Wainwright Reiterates Buy Rating on Incyte (INCY)